CARVEDILOL
Body System:
Manner of administration:Oral
Restriction
Indication: Moderate to severe heart failure
Restriction
Indication: Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 120 | # of repeats: 5 | DPMQ: $24.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
Body System:
Manner of administration:Oral
Restriction
Indication: Moderate to severe heart failure
Restriction
Indication: Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 120 | # of repeats: 5 | DPMQ: $22.84 | Max safety net: $24.38 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
Body System:
Manner of administration:Oral
Restriction
Indication: Moderate to severe heart failure
Restriction
Indication: Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 120 | # of repeats: 5 | DPMQ: $22.84 | Max safety net: $24.38 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
Body System:
Manner of administration:Oral
Restriction
Indication: Moderate to severe heart failure
Restriction
Indication: Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 0 | DPMQ: $17.93 | Max safety net: $19.47 | General Patient Charge: $22.26 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
Body System:
Manner of administration:Oral
Restriction
Indication: Moderate to severe heart failure
Restriction
Indication: Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 5 | DPMQ: $18.60 | Max safety net: $20.14 | General Patient Charge: $22.93 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
Body System:
Manner of administration:Oral
Restriction
Indication: Moderate to severe heart failure
Restriction
Indication: Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 5 | DPMQ: $18.60 | Max safety net: $20.14 | General Patient Charge: $22.93 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
Body System:
Manner of administration:Oral
Restriction
Indication: Moderate to severe heart failure
Restriction
Indication: Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 5 | DPMQ: $19.39 | Max safety net: $20.93 | General Patient Charge: $23.72 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||